Efficacy of Hepatic Arterial Infusion Chemotherapy and Radiofrequency Ablation against Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization and Vascular Variation: A Case Study
10.7180/kmj.2021.36.2.161
- Author:
Sang Yi MOON
1
;
Sang Young HAN
;
Yang-Hyun BAEK
Author Information
1. Department of Internal Medicine, On hospital, Busan, Republic of Korea
- Publication Type:Case Reports
- From:Kosin Medical Journal
2021;36(2):161-168
- CountryRepublic of Korea
- Language:English
-
Abstract:
Transarterial chemoembolization is often the first-line treatment for multiple hepatocellular carcinomas. However, hepatic arterial infusion chemotherapy is a treatment option for hepatocellular carcinoma refractory to multiple sessions of transarterial chemoembolization. Hepatic arterial infusion chemotherapy requires implantation of an appropriate port into the hepatic artery. However, it may be impossible to implant a port due to hepatic artery variation. We report a case of hepatocellular carcinoma refractory to transarterial chemoembolization and hepatic artery variation treated successfully with hepatic arterial infusion chemotherapy and radiofrequency ablation with complete response after implantation of ports in both liver lobes.
